Somayeh Taymouri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Somayeh Taymouri has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Jaleh Varshosaz
Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
17 shared publications Jaleh Varshosaz
Department of Pharmaceutics, School of Pharmacy and Novel Drug Delivery Systems Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran
10 shared publications- Mahboubeh Rostami
Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
6 shared publications Mohsen Minaiyan
6 shared publications- Farshid Hassanzadeh
Department of Medicinal Chemistry, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
5 shared publications Mina Mirian
Department of Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
4 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 62
Development of dextran based nanomicelles in a dry powder formulation for pulmonary administration of niclosamide
Inhalable dry powders containing dextran-behenic acid polymeric micelles (PM) were developed for the local delivery of niclosamide (NCL) to combat bacterial infections in the lungs of patients with cystic fi brosis. NCL loaded PM were prepared using dialysis method. Inhalable nanocomposites loaded with NCL were effectively prepared by co-spray drying the PM with inert carriers like mannitol and lactose. The physicochemical properties and in vitro deposition of the aerosolized nanocomposites were then evaluated. Additionally, the in vitro effi cacy of the prepared formulations against staphylococcus aureus was assessed using the agar well diffusion method. The optimized formulation exhibited a particle size of 333.67 ± 22.36 nm, a polydispersity index of 0.53 ± 0.08, a zeta potential of -2.90 ± 0.18 mV, an encapsulation effi ciency of 52.07 ± 3.88%, a drug loading of 19.94 ± 1.49%, and a release effi ciency of 54.04 ± 3.11%. Scanning electron microscopy also revealed that the nanomicelles were nearly spherical in shape. Both the NCL-loaded nanocomposite and PM demonstrated superior antibacterial effi cacy at higher concentrations, as compared to free NCL and drug-free PM. It can be, therefore, concluded that dry powders embedding NCL-PM may serve as a viable alternative therapy for treating lung infections in patients with cystic fi brosis.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 62
Open AccessDevelopment of dextran based nanomicelles in a dry powder formulation for pulmonary administration of niclosamide
Inhalable dry powders containing dextran-behenic acid polymeric micelles (PM) were developed for the local delivery of niclosamide (NCL) to combat bacterial infections in the lungs of patients with cystic fi brosis. NCL loaded PM were prepared using dialysis method. Inhalable nanocomposites loaded with NCL were effectively prepared by co-spray drying the PM with inert carriers like mannitol and lactose. The physicochemical properties and in vitro deposition of the aerosolized nanocomposites were then evaluated. Additionally, the in vitro effi cacy of the prepared formulations against staphylococcus aureus was assessed using the agar well diffusion method. The optimized formulation exhibited a particle size of 333.67 ± 22.36 nm, a polydispersity index of 0.53 ± 0.08, a zeta potential of -2.90 ± 0.18 mV, an encapsulation effi ciency of 52.07 ± 3.88%, a drug loading of 19.94 ± 1.49%, and a release effi ciency of 54.04 ± 3.11%. Scanning electron microscopy also revealed that the nanomicelles were nearly spherical in shape. Both the NCL-loaded nanocomposite and PM demonstrated superior antibacterial effi cacy at higher concentrations, as compared to free NCL and drug-free PM. It can be, therefore, concluded that dry powders embedding NCL-PM may serve as a viable alternative therapy for treating lung infections in patients with cystic fi brosis.
- 24 September 2025
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 40 (7) , 830-853
Fabrication and in-vitro and in-vivo evaluation of polyacrylonitrile and polyethylene oxide nanofibers loaded with resveratrol and silver nanoparticles for skin wound healing application
This study developed hybrid nanofiber scaffolds composed of polyacrylonitrile (PAN) and polyethylene oxide (PEO), loaded with resveratrol (RSV) and silver nanoparticles (Ag NPs), aiming to enhance wound healing and provide antimicrobial protection. Using electrospinning combined with a full factorial design, we optimized formulation parameters including total polymer concentration, drug/polymer ratio, and PEO/polymer ratio. We found that increasing the drug/polymer ratio resulted in an increase in fiber diameter, whereas raising the PEO concentration decreased fiber diameter. Additionally, elevating the total polymer and PEO content significantly increased the encapsulation efficiency (EE) % of RSV in the nanofibers. Moreover, higher levels of PEO positively influenced the swelling % and release efficiency (RE) %. The optimized RSV-loaded PAN/PEO nanofibers exhibited a smooth, cylindrical, and bead-free morphology with an average diameter of 217.36 ± 37.20 nm, an EE of 83.71 ± 2.28%, drug loading of 14.47 ± 1.09%, RE over 30 h of 60.95 ± 2.36%, swelling of 1111.67 ± 122.58%, ultimate tensile strength of 2.84 ± 0.34 MPa, and Young’s modulus of 26.06 ± 5.58 MPa. The incorporation of Ag NPs resulted in bead-free fibers with a slightly reduced diameter and a swelling of 1032.5 ± 106.45%.X-ray diffraction analysis confirmed the crystalline presence of both RSV and Ag NPs within the fibers. The Ag NPs imparted strong antibacterial activity, producing inhibition zones against Escherichia coli (31.66 ± 2.51 mm) and Staphylococcus aureus (18.33 ± 3.51 mm), whereas RSV alone showed no antibacterial effect. In vivo wound healing studies demonstrated a significantly faster wound healing rate for Ag NPs-RSV- nanofiber compared to other groups, with complete wound closure, full re-epithelialization, enhanced collagen deposition, and the formation of skin appendages by day 15. These findings suggest that RSV-loaded PAN/PEO nanofibers offer a promising medicated wound dressing capable of promoting tissue regeneration and preventing infection.
- 24 September 2025
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 40 (7) , 830-853
Fabrication and in-vitro and in-vivo evaluation of polyacrylonitrile and polyethylene oxide nanofibers loaded with resveratrol and silver nanoparticles for skin wound healing application
This study developed hybrid nanofiber scaffolds composed of polyacrylonitrile (PAN) and polyethylene oxide (PEO), loaded with resveratrol (RSV) and silver nanoparticles (Ag NPs), aiming to enhance wound healing and provide antimicrobial protection. Using electrospinning combined with a full factorial design, we optimized formulation parameters including total polymer concentration, drug/polymer ratio, and PEO/polymer ratio. We found that increasing the drug/polymer ratio resulted in an increase in fiber diameter, whereas raising the PEO concentration decreased fiber diameter. Additionally, elevating the total polymer and PEO content significantly increased the encapsulation efficiency (EE) % of RSV in the nanofibers. Moreover, higher levels of PEO positively influenced the swelling % and release efficiency (RE) %. The optimized RSV-loaded PAN/PEO nanofibers exhibited a smooth, cylindrical, and bead-free morphology with an average diameter of 217.36 ± 37.20 nm, an EE of 83.71 ± 2.28%, drug loading of 14.47 ± 1.09%, RE over 30 h of 60.95 ± 2.36%, swelling of 1111.67 ± 122.58%, ultimate tensile strength of 2.84 ± 0.34 MPa, and Young’s modulus of 26.06 ± 5.58 MPa. The incorporation of Ag NPs resulted in bead-free fibers with a slightly reduced diameter and a swelling of 1032.5 ± 106.45%.X-ray diffraction analysis confirmed the crystalline presence of both RSV and Ag NPs within the fibers. The Ag NPs imparted strong antibacterial activity, producing inhibition zones against Escherichia coli (31.66 ± 2.51 mm) and Staphylococcus aureus (18.33 ± 3.51 mm), whereas RSV alone showed no antibacterial effect. In vivo wound healing studies demonstrated a significantly faster wound healing rate for Ag NPs-RSV- nanofiber compared to other groups, with complete wound closure, full re-epithelialization, enhanced collagen deposition, and the formation of skin appendages by day 15. These findings suggest that RSV-loaded PAN/PEO nanofibers offer a promising medicated wound dressing capable of promoting tissue regeneration and preventing infection.
- 27 June 2025
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 16 (8) , 777-793
Characterization of enteric-coated capsules filled with colchicine loaded zein nanoparticles for colon delivery
In this study, we developed a dual pH and time-dependent formulation for targeted colonic release, aiming at minimizing adverse effect and enhancing anticancer efficacy of colchicine in the treatment of colorectal cancer. To achieve this, colchicine was loaded in zein nanoparticles (Col-Z NP) which were further optimized and encapsulated in Eudragit S100 coated capsules. A full factorial design was employed to determine the optimal condition for preparation of Col-Z NP. The optimized Col-Z NPs exhibited a spherical shape with particle size of 104.3 ± 1.6 nm, polydispersity index of 0.27 ± 0.01, zeta potential of 29.0 ± 0.1 mV, encapsulation efficiency of 59.8 ± 4.8%, release efficiency over 8 h of 45.5 ± 2.7%, and drug loading of 13.0 ± 0.0%. No notable difference in cytotoxicity was observed between free colchicine and Col-Z NPs at comparable concentrations. The cellular uptake study showed more uptake for coumarin 6 loaded Z NPs compared to free coumarin 6. Colchicine release from coated capsules was restricted to around 3% in gastric medium and increased to about 8% in simulated intestine medium, respectively. Results suggest that Eudragit S100 coated capsules containing Col-Z NP could be effective delivery system for colchicine to target colorectal tumors.
- 27 June 2025
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 16 (8) , 777-793
Characterization of enteric-coated capsules filled with colchicine loaded zein nanoparticles for colon delivery
In this study, we developed a dual pH and time-dependent formulation for targeted colonic release, aiming at minimizing adverse effect and enhancing anticancer efficacy of colchicine in the treatment of colorectal cancer. To achieve this, colchicine was loaded in zein nanoparticles (Col-Z NP) which were further optimized and encapsulated in Eudragit S100 coated capsules. A full factorial design was employed to determine the optimal condition for preparation of Col-Z NP. The optimized Col-Z NPs exhibited a spherical shape with particle size of 104.3 ± 1.6 nm, polydispersity index of 0.27 ± 0.01, zeta potential of 29.0 ± 0.1 mV, encapsulation efficiency of 59.8 ± 4.8%, release efficiency over 8 h of 45.5 ± 2.7%, and drug loading of 13.0 ± 0.0%. No notable difference in cytotoxicity was observed between free colchicine and Col-Z NPs at comparable concentrations. The cellular uptake study showed more uptake for coumarin 6 loaded Z NPs compared to free coumarin 6. Colchicine release from coated capsules was restricted to around 3% in gastric medium and increased to about 8% in simulated intestine medium, respectively. Results suggest that Eudragit S100 coated capsules containing Col-Z NP could be effective delivery system for colchicine to target colorectal tumors.
- Open Access
- 15 December 2024
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 15 (1) , 82-94
Development of folic acid functionalized bilosomes for delivery of vorinostat to breast cancer cells: Characterization and cytocidal effects on MCF-7 and 4T1 breast cancer cell lines
Purpose: Breast cancer is a prevalent form of cancer in woman. Vorinostat (VOR) is a chemotherapeutic drug that has been utilized for treatment of breast cancer, but its effectiveness is limited due to low bioavailability and several side effects. The primary aim of this study is to prepare folic acid (FA) conjugated pegylated bilosomes containing VOR for the selective targeting of breast cancer cells with the FA receptor expression. Accordingly, lithocholic acid (LCA) was used as a bile acid in bilosomes due to its anti-cancer and anti-proliferation effects. Methods: VOR loaded bilosomes were prepared using the thin-film hydration method and optimized by applying two-level fractional factorial design. Various properties of the considered bilosomes, including particle size, zeta potential (ZP), polydispersity index (PdI), encapsulation efficiency (EE) % and drug loading (DL) %, were then investigated and synthesized FA-PEG-Cholesterol was incorporated in the optimized bilosomes. The anti-cancer efficacy of VOR loaded FA-PEG- bilosomes was also evaluated in vitro using the MCF-7 and 4T1 breast cancer cell lines. Furthermore, drug-free FA-PEG-bilosomes and bilosomes were evaluated for biocompatibility in the L929 cell line. Results: The optimized VOR loaded bilosomes exhibited spherical particles with the size of 305.33 ± 18.50 nm, PdI of 0.37 ± 0.03, zeta potential of -17.66 ± 0.15 mV, EE of 92.91 ± 0.22 % and DL% of 23.64 ± 0.04%. Incorporation of FA-PEG-cholesterol in nanobilosomes increased the particle size and absolute value of zeta potential. In vitro cytotoxicity study also revealed that VOR loaded FA- PEG-bilosomes demonstrated a greater cytotoxic effect, as compared to the free VOR and VOR- bilosomes in both MCF-7 and 4T1 cancer cells. Conclusion: This showed that FA- PEG-bilosomes could be a promising formulation for the treatment of FA (+) tumors.
- 15 December 2024
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 15 (1) , 82-94
Open AccessDevelopment of folic acid functionalized bilosomes for delivery of vorinostat to breast cancer cells: Characterization and cytocidal effects on MCF-7 and 4T1 breast cancer cell lines
Purpose: Breast cancer is a prevalent form of cancer in woman. Vorinostat (VOR) is a chemotherapeutic drug that has been utilized for treatment of breast cancer, but its effectiveness is limited due to low bioavailability and several side effects. The primary aim of this study is to prepare folic acid (FA) conjugated pegylated bilosomes containing VOR for the selective targeting of breast cancer cells with the FA receptor expression. Accordingly, lithocholic acid (LCA) was used as a bile acid in bilosomes due to its anti-cancer and anti-proliferation effects. Methods: VOR loaded bilosomes were prepared using the thin-film hydration method and optimized by applying two-level fractional factorial design. Various properties of the considered bilosomes, including particle size, zeta potential (ZP), polydispersity index (PdI), encapsulation efficiency (EE) % and drug loading (DL) %, were then investigated and synthesized FA-PEG-Cholesterol was incorporated in the optimized bilosomes. The anti-cancer efficacy of VOR loaded FA-PEG- bilosomes was also evaluated in vitro using the MCF-7 and 4T1 breast cancer cell lines. Furthermore, drug-free FA-PEG-bilosomes and bilosomes were evaluated for biocompatibility in the L929 cell line. Results: The optimized VOR loaded bilosomes exhibited spherical particles with the size of 305.33 ± 18.50 nm, PdI of 0.37 ± 0.03, zeta potential of -17.66 ± 0.15 mV, EE of 92.91 ± 0.22 % and DL% of 23.64 ± 0.04%. Incorporation of FA-PEG-cholesterol in nanobilosomes increased the particle size and absolute value of zeta potential. In vitro cytotoxicity study also revealed that VOR loaded FA- PEG-bilosomes demonstrated a greater cytotoxic effect, as compared to the free VOR and VOR- bilosomes in both MCF-7 and 4T1 cancer cells. Conclusion: This showed that FA- PEG-bilosomes could be a promising formulation for the treatment of FA (+) tumors.
- 24 January 2024
- Published by Wiley in Polymers for Advanced Technologies
- Vol. 35 (1)
Biocompatible nanocomposite scaffolds based on carrageenan incorporating hydroxyapatite and hesperidin loaded nanoparticles for bone tissue regeneration
In this study, injectable and osteoinductive carrageenan (CGN)‐based composite hydrogel integrated with 1% wt/vol hydroxyapatite (HA) and hesperidin (HPN) loaded poly (3‐hydroxybutyrate‐co‐3‐hydroxyvalerate acid) nanoparticles (PHBV NPs) were developed as a scaffold for bone tissue engineering. Accordingly, HPN was encapsulated into PHBV NPs by the oil in water emulsion‐solvent evaporation technique and optimized using the fractional factorial design. Then, the effects of the amount of drug, polymer, surfactant concentration, sonication time, and the water/organic phase volume ratio on the characteristics of NPs, including particle size (PS), polydispersity index (PdI), zeta potential (ZP), drug loading (DL) % and encapsulation efficiency (EE) % were investigated. The crystalline state of HPN and the interaction between the drug and the polymer were also investigated using the x‐ray powder diffraction method and the Fourier transform infrared method, respectively. Further, CGN hydrogel was developed and loaded with optimized NPs and HA (HPN‐PHBV NPs‐CGN/HA hydrogel). The prepared hydrogel was then characterized for drug release, swelling and degradation behavior, mechanical properties, and injectability. In addition, the potential of the composite hydrogel as bone tissue scaffolds was assessed by the MTT assay, alkaline phosphatase (ALP) activity, and alizarin red S staining. The optimized formulation had the size of 353.5 nm, PdI of 0.43, EE% of 88.47%, DL% of 29.58% and the ZP of −17.4. HPN‐PHBV NPs‐CGN/HA hydrogel also showed sustained drug release, as compared to the HPN‐CGN/HA hydrogel. Further, the hydrogel containing HA showed improved mechanical properties, as compared with the HA free one. In addition, HPN‐PHBV NPs‐CGN/HA hydrogel significantly enhanced MG63 cell proliferation, ALP activity and matrix mineralization, as compared with other groups. Overall, the use of this hydrogel with enhanced osteogenic capacity could be considered as an effective approach for bone tissue engineering.
- 24 January 2024
- Published by Wiley in Polymers for Advanced Technologies
- Vol. 35 (1)
Biocompatible nanocomposite scaffolds based on carrageenan incorporating hydroxyapatite and hesperidin loaded nanoparticles for bone tissue regeneration
In this study, injectable and osteoinductive carrageenan (CGN)‐based composite hydrogel integrated with 1% wt/vol hydroxyapatite (HA) and hesperidin (HPN) loaded poly (3‐hydroxybutyrate‐co‐3‐hydroxyvalerate acid) nanoparticles (PHBV NPs) were developed as a scaffold for bone tissue engineering. Accordingly, HPN was encapsulated into PHBV NPs by the oil in water emulsion‐solvent evaporation technique and optimized using the fractional factorial design. Then, the effects of the amount of drug, polymer, surfactant concentration, sonication time, and the water/organic phase volume ratio on the characteristics of NPs, including particle size (PS), polydispersity index (PdI), zeta potential (ZP), drug loading (DL) % and encapsulation efficiency (EE) % were investigated. The crystalline state of HPN and the interaction between the drug and the polymer were also investigated using the x‐ray powder diffraction method and the Fourier transform infrared method, respectively. Further, CGN hydrogel was developed and loaded with optimized NPs and HA (HPN‐PHBV NPs‐CGN/HA hydrogel). The prepared hydrogel was then characterized for drug release, swelling and degradation behavior, mechanical properties, and injectability. In addition, the potential of the composite hydrogel as bone tissue scaffolds was assessed by the MTT assay, alkaline phosphatase (ALP) activity, and alizarin red S staining. The optimized formulation had the size of 353.5 nm, PdI of 0.43, EE% of 88.47%, DL% of 29.58% and the ZP of −17.4. HPN‐PHBV NPs‐CGN/HA hydrogel also showed sustained drug release, as compared to the HPN‐CGN/HA hydrogel. Further, the hydrogel containing HA showed improved mechanical properties, as compared with the HA free one. In addition, HPN‐PHBV NPs‐CGN/HA hydrogel significantly enhanced MG63 cell proliferation, ALP activity and matrix mineralization, as compared with other groups. Overall, the use of this hydrogel with enhanced osteogenic capacity could be considered as an effective approach for bone tissue engineering.
- 25 August 2023
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 38 (4) , 509-526
Chrysin loaded bilosomes improve the hepatoprotective effects of chrysin against CCl4 induced hepatotoxicity in mice
In the present work, chrysin loaded bilosomes were formulated, characterized and evaluated to enhance the hepatoprotective activity of drug. Accordingly, chrysin loaded bilosomes were prepared by applying the thin film hydration method; also, fractional factorial design was used to optimize the production conditions of nanoformulations. The prepared formulations were subjected to different methods of characterization; then the hepatoprotective activity of the optimized one was evaluated in the CCl4 hepatointoxicated mice model. Optimized chrysin loaded bilosomes showed a spherical shape with a particle size of 232.97 ± 23 nm, the polydispersity index of 0.35 ± 0.01, the zeta potential of −44.5 ± 1.27 mv, the entrapment efficiency of 96.77 ± 0.18%, the drug loading % of 6.46 ± 0.01 and the release efficiency of 42.25 ± 1.04 during 48 h. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical-scavenging assay demonstrated the superiority of the anti-oxidant potential of chrysin loaded bilosomes, as compared to pure chrysin. This was in agreement with histopathological investigations, showing significant improvement in serum hepatic biomarkers of CCl4 intoxicated mice treated with chrysin loaded bilosomes, as compared with free chrysin. These results, thus, showed the potential use of bilosomes to enhance the hepatoprotective activity of chrysin via oral administration.
- 25 August 2023
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 38 (4) , 509-526
Chrysin loaded bilosomes improve the hepatoprotective effects of chrysin against CCl4 induced hepatotoxicity in mice
In the present work, chrysin loaded bilosomes were formulated, characterized and evaluated to enhance the hepatoprotective activity of drug. Accordingly, chrysin loaded bilosomes were prepared by applying the thin film hydration method; also, fractional factorial design was used to optimize the production conditions of nanoformulations. The prepared formulations were subjected to different methods of characterization; then the hepatoprotective activity of the optimized one was evaluated in the CCl4 hepatointoxicated mice model. Optimized chrysin loaded bilosomes showed a spherical shape with a particle size of 232.97 ± 23 nm, the polydispersity index of 0.35 ± 0.01, the zeta potential of −44.5 ± 1.27 mv, the entrapment efficiency of 96.77 ± 0.18%, the drug loading % of 6.46 ± 0.01 and the release efficiency of 42.25 ± 1.04 during 48 h. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical-scavenging assay demonstrated the superiority of the anti-oxidant potential of chrysin loaded bilosomes, as compared to pure chrysin. This was in agreement with histopathological investigations, showing significant improvement in serum hepatic biomarkers of CCl4 intoxicated mice treated with chrysin loaded bilosomes, as compared with free chrysin. These results, thus, showed the potential use of bilosomes to enhance the hepatoprotective activity of chrysin via oral administration.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 59, e22452
Development and evaluation of wafer loaded with sertaconazole solid dispersion for the treatment of oral candidiasis
Candidiasis is one of the most common fungal infections of oral cavity in humans, causing great oral discomfort, pain and aversion to food. To develop more effective antifungal systems for the treatment of oral candidiasis, an oral mucoadhesive wafer containing sertaconazole solid dispersion (STZ-SD) was developed in this study. Dispersion of STZ in Soluplus® as a solubility enhancement excipient was done by melting, solvent evaporation and freeze drying method at various STZ to Soluplus® ratios. The optimized STZ-SD was then incorporated in the sodium carboxymethyl cellulose (SCMC) gel, xanthan gum gel, or their combination to prepare the lyophilized wafers. The swelling capacity, porosity, and mechanical, release and mucoadhesive properties of the wafers, together with their antifungal activity, were then evaluated. The melting method sample with the ratio of 8:1 showed the best results in terms of saturation solubility and dissolution rate. The STZ-SD-composite wafer exhibited higher hardness and mucoadhesion, as compared to those made of the SCMC polymer. The STZ-SD-wafer also exhibited a greater antifungal effect when compared to the STZ-wafer. The present study, thus, suggested that the STZ-SD-wafer could serve as a novel effective delivery system for oral candidiasis treatment.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 59, e22452
Open AccessDevelopment and evaluation of wafer loaded with sertaconazole solid dispersion for the treatment of oral candidiasis
Candidiasis is one of the most common fungal infections of oral cavity in humans, causing great oral discomfort, pain and aversion to food. To develop more effective antifungal systems for the treatment of oral candidiasis, an oral mucoadhesive wafer containing sertaconazole solid dispersion (STZ-SD) was developed in this study. Dispersion of STZ in Soluplus® as a solubility enhancement excipient was done by melting, solvent evaporation and freeze drying method at various STZ to Soluplus® ratios. The optimized STZ-SD was then incorporated in the sodium carboxymethyl cellulose (SCMC) gel, xanthan gum gel, or their combination to prepare the lyophilized wafers. The swelling capacity, porosity, and mechanical, release and mucoadhesive properties of the wafers, together with their antifungal activity, were then evaluated. The melting method sample with the ratio of 8:1 showed the best results in terms of saturation solubility and dissolution rate. The STZ-SD-composite wafer exhibited higher hardness and mucoadhesion, as compared to those made of the SCMC polymer. The STZ-SD-wafer also exhibited a greater antifungal effect when compared to the STZ-wafer. The present study, thus, suggested that the STZ-SD-wafer could serve as a novel effective delivery system for oral candidiasis treatment.